Premarket movers: Palantir gains on bullish call, NXP tumbles on downgrade
U.S. stock futures fell on Thursday due to rising oil prices and Treasury yields. Palantir (PLTR) rose 2.3% after a bullish call with a $250 target. NXP (NXPI) fell 2.6% following a downgrade and $110 target cut. Nova (NVMI) slipped 2.9% after a downgrade and insider sales. Rocket Pharma (RCKT) climbed 2.8% on an upgrade and positive clinical data. Wolfspeed (WOLF) jumped 17% on a $1.5B loan announcement.
How this was made
The 30-second read
Why it matters
The article aggregates several fresh analyst upgrades/downgrades and a sizable government loan, each providing immediate trading signals for the affected tickers.
Market read
The mix of analyst rating changes and a large government loan creates distinct short‑term trading opportunities across multiple tech and semiconductor stocks.
What to watch
The impact of the Department of War loan to Wolfspeed could signal increased defense‑related demand for advanced chips, benefiting the broader semiconductor supply chain.
Background
Premarket U.S. equity futures fell on higher oil and Treasury yields, while chip stocks showed mixed reactions to fresh analyst actions and a major government loan.
Ticker impact
Analyst Daniel Ives initiated coverage with Outperform rating and $250 price target, lifting pre‑market price 2.3%.
likely upside as investors price in the new bullish outlook
Coverage initiation and target increase are fresh analyst actions that typically drive short‑term demand.
Goldman Sachs upgraded Rocket Pharmaceuticals to Neutral from Sell and raised its target to $4, lifting shares 2.8% pre‑market.
likely rally as investors react to improved clinical data and analyst support
First‑day upgrade with target increase is a clear buying catalyst.
Citi downgraded NXP Semiconductors to Neutral from Buy and cut the price target to $260, sending shares down 2.6% pre‑market.
likely downside as the market digests the reduced outlook
Analyst downgrade with a large target reduction is a fresh negative catalyst.
Citi downgraded Universal Display to Sell from Neutral and lowered the price target to $71, pushing shares down 2.9% pre‑market.
likely pressure as investors react to the first sell call
First sell rating and target reduction are material negative news.
Levi Strauss reported Q3 earnings that beat profit expectations but missed revenue, causing a 1.2% pre‑market decline.
likely slight pressure as revenue miss outweighs profit beat
Earnings beat on profit but revenue miss is a nuanced catalyst, less decisive.
Wolfspeed shares jumped 17% after the Department of War announced a conditional $1.5 billion loan to the semiconductor maker.
likely significant rally as the financing supports expansion
First report of a multi‑billion government loan is a major positive catalyst.
Applied Digital reported fiscal Q1 2027 revenue of $300.4 million, far above expectations, lifting shares 4% pre‑market.
likely upside as investors reward the surprise performance
Earnings surprise is fresh but modest in scale; still a positive driver.
Market effects
Chip sector remains volatile despite strong Samsung forecast, with multiple downgrades weighing on semiconductor names.
U.S. futures slipped as higher oil and yields pressured equities, while pre‑market moves reflect sector‑specific analyst actions.
The mixed chip news may temper broader AI‑related rally, influencing global tech indices.
Counterpoint
Despite analyst downgrades, some investors may view the price drops as buying opportunities given long‑term AI demand.
Key entities
- analyst firmCiti
Issued downgrades and target cuts for Nova, NXP, and Universal Display.
- investment bankGoldman Sachs
Upgraded Rocket Pharmaceuticals and raised its price target.
- government agencyDepartment of War
Announced a conditional $1.5 billion loan to Wolfspeed.
